Molecular Aspects of the Isolated Limb Infusion Procedure

by Jüri Teras, Michael J. Carr, Jonathan S. Zager, Hidde M. Kroon
Published 2021-02-01

Clinicopathologic predictors of survival in patients with desmoplastic melanoma.

by Dale Han, Gang Han, Xiuhua Zhao, Nikhil G Rao, Jane L Messina, Suroosh S Marzban, Amod A Sarnaik, C Wayne Cruse, Vernon K Sondak, Jonathan S Zager
Published 2015-01-01

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanomaResearch in context

by Robert H.I. Andtbacka, Thomas Amatruda, John Nemunaitis, Jonathan S. Zager, John Walker, Jason A. Chesney, Kate Liu, Cheng-Pang Hsu, Cheryl A. Pickett, Janice M. Mehnert
Published 2019-09-01

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

by John E. Mullinax, John E. Mullinax, MacLean Hall, Sangeetha Prabhakaran, Jeffrey Weber, Nikhil Khushalani, Zeynep Eroglu, Andrew S. Brohl, Andrew S. Brohl, Joseph Markowitz, Joseph Markowitz, Erica Royster, Allison Richards, Valerie Stark, Jonathan S. Zager, Jonathan S. Zager, Linda Kelley, Cheryl Cox, Vernon K. Sondak, James J. Mulé, James J. Mulé, Shari Pilon-Thomas, Shari Pilon-Thomas, Amod A. Sarnaik, Amod A. Sarnaik
Published 2018-03-01

Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience.

by Nicholas DeVito, Evita Henderson, Gang Han, Damon Reed, Marilyn M Bui, Robert Lavey, Lary Robinson, Jonathan S Zager, Ricardo J Gonzalez, Vernon K Sondak, G Douglas Letson, Anthony Conley
Published 2015-01-01

Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases

by Michael J. Carr MD, MS, James Sun MD, Jonathan B. Cohen MD, Jinhong Liu MD, Andrew A. Serdiuk DO, Stephen R. Stewart CCP, Navin Doobay CAA, Andrew Duclos CRNA, David A. Seal CRNA, Junsung Choi MD, Jonathan S. Zager MD
Published 2020-12-01

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

by Jonathan S. Zager, Brian R. Gastman, Sancy Leachman, Rene C. Gonzalez, Martin D. Fleming, Laura K. Ferris, Jonhan Ho, Alexander R. Miller, Robert W. Cook, Kyle R. Covington, Kristen Meldi-Plasseraud, Brooke Middlebrook, Lewis H. Kaminester, Anthony Greisinger, Sarah I. Estrada, David M. Pariser, Lee D. Cranmer, Jane L. Messina, John T. Vetto, Jeffrey D. Wayne, Keith A. Delman, David H. Lawson, Pedram Gerami
Published 2018-02-01